Viking Therapeutics Inc
NASDAQ:VKTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
Nov Inc
NYSE:NOV
|
US |
|
C
|
Creotech Instruments SA
WSE:CRI
|
PL |
|
Luk Fook Holdings (International) Ltd
HKEX:590
|
HK |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
B
|
Brightview Holdings Inc
NYSE:BV
|
US |
|
R
|
Riley Exploration Permian Inc
AMEX:REPX
|
US |
|
Triputra Agro Persada Tbk PT
IDX:TAPG
|
ID |
|
I
|
Intchains Group Ltd
NASDAQ:ICG
|
CN |
|
N
|
N-Able Inc
NYSE:NABL
|
US |
|
Crystal Clear Electronic Material Co Ltd
SZSE:300655
|
CN |
|
Canadian National Railway Co
TSX:CNR
|
CA |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
F
|
Freemelt Holding AB (publ)
STO:FREEM
|
SE |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
CN |
|
DXC Technology Co
NYSE:DXC
|
US |
|
Capital Southwest Corp
NASDAQ:CSWC
|
US |
|
Welltower Inc
NYSE:WELL
|
US |
Wall St Price Targets
VKTX Price Targets Summary
Viking Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
VKTX is 96.01 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VKTX's stock price target?
Price Target
96.01
USD
According to Wall Street analysts, the average 1-year price target for
VKTX is 96.01 USD with a low forecast of 34.34 USD and a high forecast of 131.25 USD.